PMC:7441788 / 1144-1775
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T13 | 136-144 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T14 | 231-239 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T15 | 346-354 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T16 | 429-437 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T17 | 584-592 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 72-73 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T13 | 35-37 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T14 | 74-83 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
T15 | 208-210 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T16 | 322-324 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T17 | 404-415 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
T18 | 419-421 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 35-37 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T11 | 74-83 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
T12 | 208-210 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T13 | 322-324 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T14 | 419-421 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T11 | 136-144 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T12 | 231-239 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T13 | 346-354 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T14 | 429-437 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T15 | 584-592 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 146-249 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
T16 | 250-541 | Sentence | denotes | Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies. |
T17 | 543-545 | Sentence | denotes | 1. |
T18 | 547-559 | Sentence | denotes | Introduction |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
120 | 584-592 | Disease | denotes | COVID-19 | MESH:C000657245 |
46 | 122-130 | Species | denotes | patients | Tax:9606 |
47 | 240-248 | Species | denotes | patients | Tax:9606 |
55 | 35-41 | Chemical | denotes | CQ/HCQ | |
56 | 74-83 | Chemical | denotes | macrolide | MESH:D018942 |
57 | 208-210 | Chemical | denotes | CQ | MESH:D002738 |
58 | 211-214 | Chemical | denotes | HCQ | MESH:D006886 |
59 | 322-324 | Chemical | denotes | CQ | MESH:D002738 |
60 | 325-328 | Chemical | denotes | HCQ | MESH:D006886 |
61 | 419-421 | Chemical | denotes | CQ | MESH:D002738 |
62 | 422-425 | Chemical | denotes | HCQ | MESH:D006886 |
70 | 136-144 | Disease | denotes | COVID-19 | MESH:C000657245 |
71 | 231-239 | Disease | denotes | COVID-19 | MESH:C000657245 |
72 | 346-354 | Disease | denotes | COVID-19 | MESH:C000657245 |
73 | 429-437 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T5 | 572-579 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T11 | 136-144 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 231-239 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T13 | 346-354 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T14 | 429-437 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T15 | 560-582 | Disease | denotes | Coronavirus disease-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T16 | 584-592 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 173-194 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
46 | 122-130 | Species | denotes | patients | Tax:9606 |
47 | 240-248 | Species | denotes | patients | Tax:9606 |
55 | 35-41 | Chemical | denotes | CQ/HCQ | |
56 | 74-83 | Chemical | denotes | macrolide | MESH:D018942 |
57 | 208-210 | Chemical | denotes | CQ | MESH:D002738 |
58 | 211-214 | Chemical | denotes | HCQ | MESH:D006886 |
59 | 322-324 | Chemical | denotes | CQ | MESH:D002738 |
60 | 325-328 | Chemical | denotes | HCQ | MESH:D006886 |
61 | 419-421 | Chemical | denotes | CQ | MESH:D002738 |
62 | 422-425 | Chemical | denotes | HCQ | MESH:D006886 |
70 | 136-144 | Disease | denotes | COVID-19 | MESH:C000657245 |
71 | 231-239 | Disease | denotes | COVID-19 | MESH:C000657245 |
72 | 346-354 | Disease | denotes | COVID-19 | MESH:C000657245 |
73 | 429-437 | Disease | denotes | COVID-19 | MESH:C000657245 |
119 | 560-582 | Disease | denotes | Coronavirus disease-19 | MESH:C000657245 |
120 | 584-592 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 146-249 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
T16 | 250-541 | Sentence | denotes | Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies. |
T17 | 543-545 | Sentence | denotes | 1. |
T18 | 547-559 | Sentence | denotes | Introduction |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 173-194 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |